GlassScriptPhysician profile
Tracy K Barlow
NPI 1548548514
$4,062.46
in general payments reported to CMS, 2019-2025
29 companies · $157 in 2025
The $157 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,385 · 2022: $1,424 · 2023: $437 · 2024: $661 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,181 · Education: $72.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,181.31 |
| Education | $72.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $996.30 | 2021-2025 | Breztri, Fasenra, Tezspire |
| Grifols USA, LLC | $607.73 | 2021-2024 | Prolastin-C Liquid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $413.28 | 2021-2023 | Stiolto Respimat, Spiriva Respimat, Combivent Respimat |
| Glaxosmithkline, LLC. | $354.37 | 2021-2025 | Trelegy Ellipta, Arexvy |
| Inspire Medical Systems, INC. | $302.40 | 2023-2024 | Inspire |
| Baxter Healthcare | $269.80 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Genzyme Corporation | $109.34 | 2021-2024 | |
| United Therapeutics Corporation | $105.06 | 2021-2023 | |
| Jazz Pharmaceuticals INC. | $102.53 | 2021-2025 | |
| Paratek Pharmaceuticals, INC. | $85.71 | 2021-2022 | |
| Mylan Specialty L.P. | $73.81 | 2021-2022 | |
| Amgen INC. | $72.56 | 2022 | |
| Philips North America LLC | $64.14 | 2021-2025 | Vest Therapy Und |
| Takeda Pharmaceuticals U.S.A., INC. | $63.01 | 2021-2023 | Glassia |
| Insmed, INC. | $60.49 | 2023-2025 | Arikayce, Brinsupri |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inogen, INC. | $58.46 | 2022-2024 | |
| Boston Scientific Corporation | $51.34 | 2024 | Wavewriter Alpha Prime 16 |
| Axsome Therapeutics, INC. | $36.58 | 2022-2023 | Sunosi |
| Ethicon INC. | $35.04 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $34.64 | 2022-2023 | Airduo Digihaler |
| Sunovion Pharmaceuticals INC. | $33.48 | 2021 | |
| Ani Pharmaceuticals, INC. | $26.75 | 2025 | Purified Cortrophin Gel |
| Shionogi INC | $19.44 | 2022 | |
| Genentech USA, INC. | $17.45 | 2022 | |
| Phadia US INC. | $15.32 | 2021 | |
| Gilead Sciences, INC. | $14.58 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $14.17 | 2023 | Dupixent |
| Electromed, INC. | $12.85 | 2021 | |
| Abbvie INC. | $11.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Barlow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.